MX386586B - Cristal de base libre de derivados benzofurano y método de preparación. - Google Patents
Cristal de base libre de derivados benzofurano y método de preparación.Info
- Publication number
- MX386586B MX386586B MX2019012967A MX2019012967A MX386586B MX 386586 B MX386586 B MX 386586B MX 2019012967 A MX2019012967 A MX 2019012967A MX 2019012967 A MX2019012967 A MX 2019012967A MX 386586 B MX386586 B MX 386586B
- Authority
- MX
- Mexico
- Prior art keywords
- crystal
- preparation
- benzofuran
- free base
- present
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 9
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000012458 free base Substances 0.000 title abstract 2
- MZAUQUVYPHLLDF-UHFFFAOYSA-N 1-benzofuran-4-carboxamide Chemical compound NC(=O)C1=CC=CC2=C1C=CO2 MZAUQUVYPHLLDF-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000001907 coumarones Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a un cristal de una base libre de derivado de benzofurano y a un método de preparación. Específicamente, la presente invención se refiere al cristal A, cristal B, cristal C y cristal D de N-((4,6-dimetil-2-carbonil-1,2-dihidropiridin-3-il)metil)-5-etilo-6-(etil(tetrahidro-2H-piran)4-il)amino)-2-(piperidin-1-ilmetil)benzofuran-4-carboxamida y un método de preparación para los cristales. Los cristales del compuesto de fórmula (I) de la presente invención tienen una gran estabilidad cristalina y proporcionan usos mejorados en el tratamiento clínico (ver fórmula I).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710350574 | 2017-05-18 | ||
| PCT/CN2018/087272 WO2018210302A1 (zh) | 2017-05-18 | 2018-05-17 | 一种苯并呋喃类衍生物游离碱的晶型及制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019012967A MX2019012967A (es) | 2020-01-20 |
| MX386586B true MX386586B (es) | 2025-03-19 |
Family
ID=64273357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019012967A MX386586B (es) | 2017-05-18 | 2018-05-17 | Cristal de base libre de derivados benzofurano y método de preparación. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11155537B2 (es) |
| EP (1) | EP3626715A4 (es) |
| JP (1) | JP7257328B2 (es) |
| KR (1) | KR102612379B1 (es) |
| CN (1) | CN109937200B (es) |
| AU (1) | AU2018269268B2 (es) |
| CA (1) | CA3058496A1 (es) |
| MX (1) | MX386586B (es) |
| MY (1) | MY198008A (es) |
| TW (1) | TWI772424B (es) |
| WO (1) | WO2018210302A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202108578A (zh) * | 2019-05-10 | 2021-03-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 6-取代氨基苯并呋喃化合物的製備方法 |
| CN117956995A (zh) * | 2021-08-30 | 2024-04-30 | 江苏恒瑞医药股份有限公司 | 一种ezh2抑制剂用于制备治疗t细胞淋巴瘤的药物的用途 |
| MX2024004579A (es) * | 2021-10-15 | 2024-04-30 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Metodo de preparacion de derivado de benzofurano. |
| AU2023295387A1 (en) | 2022-06-13 | 2025-01-09 | Treeline Biosciences, Inc. | 1,8-naphthyridin-2-one heterobifunctional bcl6 degraders |
| KR20250023483A (ko) | 2022-06-13 | 2025-02-18 | 트리라인 바이오사이언시스, 인크. | 퀴놀론 bcl6 이작용성 분해제 |
| WO2024260368A1 (zh) * | 2023-06-19 | 2024-12-26 | 江苏恒瑞医药股份有限公司 | 一种苯并呋喃衍生物及其中间体的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012005805A1 (en) | 2010-05-07 | 2012-01-12 | Glaxosmithkline Llc | Azaindazoles |
| US8846935B2 (en) | 2010-05-07 | 2014-09-30 | Glaxosmithkline Llc | Indazoles |
| SG180031A1 (en) | 2010-10-15 | 2012-05-30 | Agency Science Tech & Res | Combination treatment of cancer |
| WO2012118812A2 (en) * | 2011-02-28 | 2012-09-07 | Epizyme, Inc. | Substituted 6,5-fused bicyclic heteroaryl compounds |
| JO3363B1 (ar) | 2011-04-13 | 2019-03-13 | Epizyme Inc | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس |
| TW201733984A (zh) | 2011-04-13 | 2017-10-01 | 雅酶股份有限公司 | 經取代之苯化合物 |
| US9073924B2 (en) | 2011-09-13 | 2015-07-07 | Glaxosmithkline Llc | Azaindazoles |
| US9730925B2 (en) | 2011-09-30 | 2017-08-15 | Glaxomithkline Llc | Methods of treating cancer |
| WO2013067300A1 (en) | 2011-11-04 | 2013-05-10 | Glaxosmithkline Intellectual Property (No. 2) Limited | Method of treatment |
| UA111305C2 (uk) | 2012-12-21 | 2016-04-11 | Пфайзер Інк. | Конденсовані лактами арилу та гетероарилу |
| PL3121175T3 (pl) | 2014-03-17 | 2020-06-01 | Daiichi Sankyo Company, Limited | Pochodne 1,3-benzodioksolu jako inhibitory ezh1 i/lub ezh2 |
| SI3378859T1 (sl) * | 2015-11-19 | 2020-03-31 | Jiangsu Hengrui Medicine Co., Ltd., | Derivat benzofurana, postopek za njegovo pripravo in njegova uporaba v medicini |
-
2018
- 2018-05-17 EP EP18802467.3A patent/EP3626715A4/en not_active Withdrawn
- 2018-05-17 WO PCT/CN2018/087272 patent/WO2018210302A1/zh not_active Ceased
- 2018-05-17 JP JP2019557445A patent/JP7257328B2/ja active Active
- 2018-05-17 MX MX2019012967A patent/MX386586B/es unknown
- 2018-05-17 CA CA3058496A patent/CA3058496A1/en active Pending
- 2018-05-17 AU AU2018269268A patent/AU2018269268B2/en active Active
- 2018-05-17 KR KR1020197035449A patent/KR102612379B1/ko active Active
- 2018-05-17 CN CN201880004345.0A patent/CN109937200B/zh active Active
- 2018-05-17 MY MYPI2019006338A patent/MY198008A/en unknown
- 2018-05-17 US US16/612,168 patent/US11155537B2/en active Active
- 2018-05-17 TW TW107116783A patent/TWI772424B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| MY198008A (en) | 2023-07-25 |
| CN109937200B (zh) | 2020-09-11 |
| EP3626715A1 (en) | 2020-03-25 |
| JP2020519569A (ja) | 2020-07-02 |
| US20210130333A1 (en) | 2021-05-06 |
| RU2019136363A (ru) | 2021-06-18 |
| MX2019012967A (es) | 2020-01-20 |
| KR102612379B1 (ko) | 2023-12-12 |
| CA3058496A1 (en) | 2018-11-22 |
| BR112019021023A2 (pt) | 2020-05-05 |
| TWI772424B (zh) | 2022-08-01 |
| US11155537B2 (en) | 2021-10-26 |
| AU2018269268A1 (en) | 2019-11-07 |
| RU2019136363A3 (es) | 2021-12-29 |
| JP7257328B2 (ja) | 2023-04-13 |
| KR20200006551A (ko) | 2020-01-20 |
| EP3626715A4 (en) | 2021-03-24 |
| AU2018269268B2 (en) | 2022-01-06 |
| TW201900639A (zh) | 2019-01-01 |
| WO2018210302A1 (zh) | 2018-11-22 |
| CN109937200A (zh) | 2019-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20250289A1 (ar) | صور بلورية جديدة | |
| MY198008A (en) | Crystal of benzofuran derivative free base and preparation method | |
| EA202090688A1 (ru) | Бис-амидные соединения, активирующие саркомер, и варианты их применения | |
| MX383856B (es) | Compuestos y composiciones para inhibir la actividad de shp2. | |
| EA201890450A1 (ru) | Циклические динуклеотидные соединения в качестве агонистов sting | |
| EA201891191A1 (ru) | 2-замещенные соединения хиназолина, содержащие замещенную гетероциклическую группу, и способы их применения | |
| EA201691401A1 (ru) | Индазольные соединения в качестве ингибиторов irak4 | |
| EA201691428A1 (ru) | Бициклические гетероциклические производные в качестве ингибиторов irak4 | |
| JOP20190174B1 (ar) | مثبطات jak1 انتقائية | |
| EA201492023A1 (ru) | Регуляторы пути комплемента и их применение | |
| EP4324525A3 (en) | Hydrochloride salt form for ezh2 inhibition | |
| CL2014003181A1 (es) | Compuestos derivados de benzamidas n- sustituidas o piridinamidas n-sustituidas; composicion farmaceutica que los comprende; metodo de tratamiento; y su uso para el tratamiento de enfermedades o trastornos seleccionados de dolor, depresion y enfermedades cardiovasculares, respiratorias o psiquiatricas o combinaciones de estas. | |
| EA201491824A1 (ru) | Производные бензамида для ингибирования активности abl1, abl2 и bcr-abl1 | |
| EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
| TN2018000106A1 (en) | Farnesoid x receptor modulators | |
| JO3430B1 (ar) | مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
| PH12015502192A1 (en) | Novel compounds | |
| EA201790246A1 (ru) | Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы | |
| EA201391288A1 (ru) | Производные пиразолоспирокетонов для применения в качестве ингибиторов ацетил-коа-карбоксилаз | |
| EA201300436A8 (ru) | Совместные кристаллы и соли ингибиторов ccr3 | |
| BR112019003320A2 (pt) | compostos de heteroaril carboxamida como inibidores de ripk2 | |
| TN2019000204A1 (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| CY1121484T1 (el) | Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4 | |
| JOP20190050A1 (ar) | مثبطات دوبامين-b-هيدروكسيلاز تخترق حاجز المخ الدموي | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды |